poisar

Stocks · News reference

DaVita Inc. Reports Third Quarter 2026 Financial Results

DaVita Inc. announced its financial and operating results for the third quarter ended September 30, 2026, reporting consolidated revenues of $3.578 billion.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

DVA
Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Lowey Dannenberg P.C.

    Lowey Dannenberg, P.C. is Investigating DaVita Inc. (NYSE: DVA) for Potential Violations of the Federal Securities Laws

    Law firm Lowey Dannenberg is investigating DaVita Inc. for potential securities law violations following the HHS announcement of a coordinated strategy to revitalize American kidney care by introducing competition measures and penalizing market dominance in the dialysis industry. DaVita's stock fell 6.23% ($11.65 per share) on October 20, 2026, following the announcement, as investors question whether the company adequately disclosed regulatory and competitive risks.

    DVA